Major pharmaceutical firms to fare worse in Q3

Published: 2012-10-17 06:58:00

Updated: 2012-10-17 06:58:00

The outlook for Korean listed drug companies' third quarter earnings is taking a turn for the worse as the government forced down prices of medicines in April, a report showed Monday.

Hi Investment & Securities downgraded the third-quarter earnings outlook for major pharmaceutical companies, while Yuhan Corp. and Hanmi Pharmaceutical are expected to perform better during the fourth quarter, ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.